Vanguard Group
SYNH

Vanguard Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Vanguard Group’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,283,488
Closed -$433M – 4571
2023
Q2 		$433M Sell
10,283,488
-165,675
-2% -$6.7M 0.01% 1009
2023
Q1 		$372M Buy
10,449,163
+102,876
+1% +$3.73M 0.01% 1076
2022
Q4 		$380M Buy
10,346,287
+496,929
+5% +$19.6M 0.01% 1038
2022
Q3 		$464M Buy
9,849,358
+181,422
+2% +$11.7M 0.01% 881
2022
Q2 		$693M Sell
9,667,936
-56,410
-0.6% -$4.12M 0.02% 695
2022
Q1 		$787M Buy
9,724,346
+30,725
+0.3% +$2.6M 0.02% 717
2021
Q4 		$995M Buy
9,693,621
+43,783
+0.5% +$4.2M 0.02% 660
2021
Q3 		$844M Sell
9,649,838
-63,333
-0.7% -$5.73M 0.02% 710
2021
Q2 		$869M Buy
9,713,171
+1,804,565
+23% +$152M 0.02% 704
2021
Q1 		$600M Buy
7,908,606
+1,117,421
+16% +$84.2M 0.02% 844
2020
Q4 		$463M Sell
6,791,185
-1,660,383
-20% -$104M 0.01% 921
2020
Q3 		$449M Buy
8,451,568
+481,343
+6% +$28.7M 0.01% 823
2020
Q2 		$464M Sell
7,970,225
-248,693
-3% -$13.4M 0.02% 794
2020
Q1 		$324M Buy
8,218,918
+166,078
+2% +$9.71M 0.01% 865
2019
Q4 		$479M Buy
8,052,840
+113,369
+1% +$6.09M 0.02% 839
2019
Q3 		$422M Buy
7,939,471
+293,017
+4% +$15M 0.02% 880
2019
Q2 		$391M Buy
7,646,454
+415,522
+6% +$19.3M 0.01% 921
2019
Q1 		$374M Buy
7,230,932
+125,874
+2% +$6.1M 0.01% 940
2018
Q4 		$280M Buy
7,105,058
+190,835
+3% +$8.87M 0.01% 1030
2018
Q3 		$356M Buy
6,914,223
+624,991
+10% +$30.6M 0.01% 1006
2018
Q2 		$295M Buy
6,289,232
+5,500
+0.1% +$228K 0.01% 1089
2018
Q1 		$223M Buy
6,283,732
+75,946
+1% +$2.97M 0.01% 1216
2017
Q4 		$271M Sell
6,207,786
-1,587,243
-20% -$74.2M 0.01% 1090
2017
Q3 		$408M Buy
7,795,029
+1,608,636
+26% +$89.7M 0.02% 814
2017
Q2 		$362M Buy
6,186,393
+142,349
+2% +$7.4M 0.02% 866
2017
Q1 		$277M Buy
6,044,044
+386,699
+7% +$19.2M 0.01% 1006
2016
Q4 		$298M Buy
5,657,345
+71,860
+1% +$3.48M 0.02% 916
2016
Q3 		$249M Buy
5,585,485
+852,547
+18% +$37M 0.01% 975
2016
Q2 		$180M Buy
4,732,938
+1,087,652
+30% +$47.8M 0.01% 1112
2016
Q1 		$150M Buy
3,645,286
+602,467
+20% +$24.8M 0.01% 1190
2015
Q4 		$148M Buy
3,042,819
+632,909
+26% +$28.2M 0.01% 1193
2015
Q3 		$96.4M Buy
2,409,910
+1,002,875
+71% +$43.8M 0.01% 1457
2015
Q2 		$56.5M Buy
1,407,035
+696,551
+98% +$24M ﹤0.01% 1871
2015
Q1 		$23.3M Buy
710,484
+135,023
+23% +$3.73M ﹤0.01% 2264
2014
Q4 		$14.8M Buy
+575,461
New +$13.7M ﹤0.01% 2382

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vanguard Group's SYNH Position: Q3 2023 in Review

Vanguard Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 10,283,488 shares — an estimated $433M sold.

Vanguard Group first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $995M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Vanguard Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Vanguard Group sold 10,283,488 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $433M.
  • Vanguard Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
  • Vanguard Group's Syneos Health, Inc. Class A Common Stock position peaked at $995M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.